Publication of final data from the TRAPEZE trial

Posted on February 2, 2016 by Sitemaster

Some 2½ years ago, James presented data from the TRAPEZE trial at the annual meeting of the American Society of Clinical Oncology in Chicago. At the time, we described these data as “unsurprising.” … READ MORE …

Filed under: Management, Treatment | Tagged: , , , , , , , | Leave a comment »

What’s being presented at ASCO this year: I

Posted on May 15, 2014 by Sitemaster

So here are some links to some initial key papers to be presented at ASCO this year. These four papers all address important issues affecting the treatment of metastatic and later stages of prostate cancer. … READ MORE …

Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: , , , | Leave a comment »

Statins in clinical trials for advanced forms of prostate cancer

Posted on April 10, 2013 by Sitemaster

An editorial  by Freeman and Solomon (“Statin drugs and prostate cancer: time to consider proactive strategies in patients“) in the April issue of the Journal of Urology has proposed the idea of combining abiraterone acetate with a statin as a method to treat men with castration-resistant prostate cancer (CRPC). … READ MORE …

Filed under: Drugs in development, Living with Prostate Cancer, Management, Treatment | Tagged: , , , | Leave a comment »

US FDA approves cabazitaxel for late-stage prostate cancer

Posted on June 17, 2010 by Sitemaster

Somewhat “out of the blue,” the US Food and Drug Administration (FDA), earlier today, approved Sanofi-Aventis’s “second-generation” taxane, cabazitaxel (Jevtana®) in combination with prednisone for the treatment of men with metastatic, castration-resistant prostate cancer (mCRPC) who have already progressed after treatment with docetaxel. … READ MORE …

Filed under: Drugs in development, Management, Treatment | Tagged: , , , , , | 2 Comments »

  • Donate

  • Disclaimer

    News and information provided on this site should not be used for diagnosing or treating any health problem or disease.

    The “New” Prostate Cancer InfoLink is intended for informational purposes only. It is not engaged in rendering medical advice or professional services and is not a substitute for professional care. If you have or suspect you may have a health problem, please consult your healthcare provider.

  • Hot Posts …

  • … and Archives